Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Viral Infections (clinicaltrials.gov) - Mar 18, 2024 - P4 | N=80 | Recruiting | Sponsor: Valenta Pharm JSC
New P4 trial • Infectious Disease • Influenza • Respiratory Diseases
|